{
  "articles": [
    {
      "id": "article_1769083064768",
      "title": "NK cell-mediated tumor cell killing by bispecific innate cell engagers induces ADCC-mediated activation of primary human dendritic cells.",
      "summary": "Bispecific antibodies targeting NK cells can activate dendritic cells and enhance anti-tumor immune responses, potentially improving cancer treatment.",
      "url": "https://pubmed.ncbi.nlm.nih.gov/41548123/",
      "source": "PubMed",
      "category": "Emerging Research",
      "cancer_types": [
        "General"
      ],
      "quality_score": 12,
      "pub_date": "2026-01",
      "added_date": "2026-01-22T11:57:44.768Z"
    },
    {
      "id": "article_1769079708203",
      "title": "Antibodies to watch in 2026.",
      "summary": "Here's a concise summary focusing on the key points:\n\nA comprehensive review tracks the growing landscape of antibody therapeutics, highlighting increasing global development and diverse clinical pipelines across various medical indications.",
      "url": "https://pubmed.ncbi.nlm.nih.gov/41560619/",
      "source": "PubMed",
      "category": "Clinical Trials",
      "cancer_types": [
        "Leukemia"
      ],
      "quality_score": 15,
      "pub_date": "2026-01",
      "added_date": "2026-01-22T11:01:48.203Z"
    }
  ],
  "last_updated": "2026-01-22T11:57:44.768Z",
  "total_count": 2
}